Selected Topics Relating to Raising Private Capital and Negotiating Investment Terms
ADLSI Commercial Transactions Series Raising Capital from Private Investors or the Crowd SCOPE This paper comprises a selection of articles prepared by […]
Author: Andrew
March 2019
Advised Clinician Holdings on its investment round to raise approx. US$2.4m from NZ investors and Australian and Singapore VCs.
November 2018
Advised Massey University on the sale of its ‘Ferri Pro’ technology (which combats iron deficiency) to Nestle.
September 2018
Advised the investor consortium in relation to their NZ$15m investment in leading medical cannabis start-up, Helius Therapeutics.
Employee share plans – update and refresher for early stage companies
For early stage high growth companies, shares or share options are an important component of the remuneration package for key employees, to […]
November 2017
Acted for Fergus Software in relation to aggregate investments of $A3.5m by an Australian venture capital fund and a large Australian corporate.
February 2016
Andrew was appointed to the board of high growth financial services company Enable-Me – www.enableme.co.nz
January 2016
Acted for Evergreen Capital (a New York based private equity firm) on the acquisition of the Wormald Group of companies in Australia […]
January 2016
Acted for the shareholders of The New Zealand School of Food Hygiene Limited and related companies (also known as Burwater Pacific group) […]
October 2015
Acted for the shareholders of NZ Tertiary Education Group (otherwise known as Cornerstone Group) in respect of the sale of that group […]